Skip to main content
Premium Trial:

Request an Annual Quote

The Bioethics Draft Picks

The membership of the Presidential Commission for the Study of Bioethical Issues was announced this week, and Summer Johnson, a blogger at the American Journal of Bioethics' blog, says she is "boggled" by the commission's composition. While the membership is highly qualified, she writes, the real issue is that it's unclear how the commission will fulfill the diverse obligations of its charter as the list of members "lacks creativity in terms of what a bioethics commission could have done," specifically exploring "revolutionary" scientific research.

However, among disciplines included on the panel are genetics – represented by Raju Kucherlapati from the Harvard Medical School Department of Genetics – HIV/AIDS, and cancer.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.